TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Swedish Orphan Biovitrum International AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 22,627 | 22,877 | 35,578 |
Financial expenses | 92,986 | 95,168 | 104,162 |
Earnings before taxes | -90,331 | -145,394 | -92,348 |
EBITDA | 1,240 | -29,792 | 34,104 |
Total assets | 5,682,974 | 5,643,659 | 5,928,706 |
Current assets | 399,379 | 184,854 | 51,921 |
Current liabilities | 14,093 | 15,835 | 55,597 |
Equity capital | 1,167,762 | 1,050,022 | 961,121 |
- share capital | 588 | 607 | 652 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 20.5% | 18.6% | 16.2% |
Turnover per employee | |||
Profit as a percentage of turnover | -399.2% | -635.5% | -259.6% |
Return on assets (ROA) | 0.0% | -0.9% | 0.2% |
Current ratio | 2833.9% | 1167.4% | 93.4% |
Return on equity (ROE) | -7.7% | -13.8% | -9.6% |
Change turnover | 438 | -10,243 | -10,878 |
Change turnover % | 2% | -31% | -23% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.